-
-
-
-
-
-
-
Q2 Investor Summit Virtual Live Wednesday June 24
-
-
-
-
-
-
-
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast
-
-
-
-
-
-
-
Exozymes (EXOZ) files $50M mixed shelf
-
-
-
-
-
-
-
CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference
-
-
-
-
-
-
-
eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity
-
-
-
-
-
-
-
eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health
-
-
-
-
447,651 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

